| Price | 53.17 |
| Price Change Today | 0.00 (0.00%) |
| P&P rating | ![]() |
| Zacks Rank | 2 - BUY |
| Open Price | $0.00 |
| Previous Close | $53.17 |
| Daily Range | $0.00 - $0.00 |
| 52-Week Range | $25.57 - $79.40 |
| Volume | 0 |
| Illumina Inc. is a leading developer of next-generation tools for the large-scale analysis of genetic variation and function. The company's tools will provide information that could be used to improve drugs and therapies, customize diagnoses and treatment, and cure disease. The company is developing a comprehensive line of products that can address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
They have turned the company into profitable operations for the last two quarters and has a projected profit growth of about 40%.On 09/08 the stock was selling for $45.67 and it closed on 10/16/08 for $29.27 which is an increase of $1.37 from previous day.
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment